Beauty

Pharma Hemp optimistic about potential in APAC regardless of regulatory hurdles


CBD is a compound that is predominantly found in cannabis plants. It is a non-psychoactive compound with multiple beneficial effects on the human body, making it a sought-after material in the health and wellness sector.

As a cosmetic product, CBD has gained significant attention for its anti-inflammatory properties which help target acne-prone skin, sensitive skin, as well as ageing skin.

Additionally, the use of CBD has been explored in other beauty categories, including hair care and oral care.

Since the hype kicked off, it has been found in beauty products from brands such as Kiehl’s, Colgate, The Body Shop, E.L.F, and Milk Makeup.

In Asia Pacific, markets such as Australia, China, Japan, South Korea, and Thailand were touted as major areas for growth for CBD beauty.

However, it hit a major hurdle when China introduced legislation to prohibit CBD use in cosmetics in 2021.

The regulatory uncertainties in the region have caused CBD beauty companies such as Balanced Health Botanicals, which owned skin care brand BOTA to shut down plans to expand​ in APAC completely, shifting focus to Europe and the US.

Despite this, Slovenian producer and supplier Pharma Hemp was still positive about the potential of CBD in APAC.

“We saw a boom with CBD in general, the hype was really big. Now, it’s started to normalise but there’s still potential. It’s really good for anxiety and sleep issue, people use it for pain as well. In cosmetics, it is very good for acne and trouble skin. We believe in its potential because the benefits of CBD are just numerous.



Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button